Why Dollar Tree Looks Better Than Dollar General After Earnings
When Dollar General reported its fiscal third-quarter financial results early Thursday, earnings did not live up to the expectations set earlier last week by rival Dollar Tree.
All Work
Chris Lange
Guess Misses Q3 Earnings
Guess’, Inc. (NYSE: GES) reported fiscal third-quarter financial results after markets closed on Wednesday. The company said that it had $0.11 in earnings per share (EPS) and $536.3 million in revenue. Thomson Reuters had…
What to Look for in Dollar General Earnings
Dollar General Corp. (NYSE: DG) is scheduled to release its fiscal third quarter earnings report before the markets open on Thursday. The consensus estimates from Thomson Reuters are calling for $0.93 in EPS and…
Superconductor Tech Soars on Department of Energy Award
Superconductor Technologies shares skyrocketed on Wednesday after the company was recognized and awarded $4.5 million by the U.S. Department of Energy.
Costamare Prices Secondary Offering
Costamare intends to offer 12 million shares at $6 apiece in a secondary offering valued up to almost $83 million.
What to Expect From Kroger Earnings
Kroger is scheduled to release its fiscal third-quarter financial results before the markets open on Thursday.
SiteOne Prices Secondary Offering
SiteOne Landscape Supply intends to offer 9 million shares at $33 apiece in a secondary offering valued up to more than $341 million.
American Eagle Trips Over Missed Guidance
American Eagle Outfitters reported its fiscal third-quarter financial results before the markets opened on Wednesday.
FDA Requests Additional Data on Amicus’ Fabry Disease Treatment
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is watching its shares drop on Tuesday after the company provided an update on its regulatory pathway for its Fabry Disease treatment. After the company had several collaborative discussions…
Nivalis Therapeutics Crumbles on Failed Mid-Stage Trial
Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its…
Genetic Technologies Practically Doubles on Licensing Agreement
Shares of Genetic Technologies practically doubled in Tuesday's session after the company announced the signing of an exclusive worldwide license agreement with the University of Melbourne.
What to Expect From American Eagle Earnings
American Eagle Outfitters is scheduled to release its most recent earnings report before the markets open on Wednesday.
Ichor Announces Potential Pricing for IPO
Ichor Holdings has filed with the U.S. Securities and Exchange Commission regarding its initial public offering (IPO).
Impinj Closes in on Secondary Offering
Impinj intends to offer more than 3 million shares in a secondary offering that could be valued up to more than $107 million.
Cotiviti Gears Up for Secondary Offering
Cotiviti intends to offer 10 million shares in a secondary offering that could be valued up to more than $361 million.
Tiffany Rises on Solid Earnings
Tiffany reported better-than-expected fiscal third-quarter financial earnings before the markets opened on Tuesday.
Mauser Updates IPO Filing
Mauser Group has registered an amended Form F-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were mentioned in the filing. The company intends to…
Recro Pharma Rises on Late Stage Win
Recro Pharma shares saw a handy gain on Monday after the company announced positive late-stage results on its acute postoperative pain treatment.
PhaseRx More Than Doubles on Key FDA Approval
Shares of PhaseRx more than doubled on Monday after the company announced that it received a key FDA approval for its rare liver disorder treatment.
What to Expect From Tiffany Earnings
Tiffany is scheduled to release its fiscal third-quarter financial results before the markets open on Tuesday.